Amphastar Pharmaceuticals Ownership | Who Owns Amphastar Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Amphastar Pharmaceuticals Ownership Summary


Amphastar Pharmaceuticals is owned by 72.73% institutional investors, 22.41% insiders, and 4.86% retail investors. Blackrock is the largest institutional shareholder, holding 12.33% of AMPH shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.00% of its assets in Amphastar Pharmaceuticals shares.

AMPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAmphastar Pharmaceuticals72.73%22.41%4.86%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.90%10.53%54.58%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.94M12.33%$237.70M
Vanguard group2.67M5.54%$106.91M
Federated hermes1.94M4.03%$77.79M
Td asset management1.69M3.51%$67.66M
Neuberger berman group1.62M3.37%$64.90M
State street1.53M3.17%$61.18M
Fuller & thaler asset management1.27M2.64%$50.91M
Epoch investment partners1.08M2.24%$43.15M
Dimensional fund advisors lp1.07M2.22%$42.81M
Geode capital management906.35K1.88%$36.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boone capital management495.09K5.17%$19.80M
Lam group130.80K4.41%$5.23M
Aurora investment counsel54.47K1.28%$2.18M
Mesirow institutional investment management353.45K1.24%$14.14M
Alphacentric advisors25.00K0.74%$1.00M
Granite investment partners397.51K0.66%$15.90M
Bridge city capital48.95K0.66%$1.96M
Moody aldrich partners55.73K0.43%$2.23M
Redwood investments26.77K0.36%$1.06M
Portolan capital management108.86K0.36%$4.35M

Top Buyers

HolderShares% AssetsChange
Td asset management1.69M0.06%680.98K
Millennium management738.75K0.01%338.65K
Epoch investment partners1.08M0.20%280.39K
Marshall wace, llp227.13K0.01%227.13K
American century companies740.41K0.02%121.76K

Top Sellers

HolderShares% AssetsChange
Oberweis asset management inc/135.06K0.33%-282.81K
Jacobs levy equity management28.62K0.00%-166.37K
Lsv asset management80.40K0.01%-144.37K
Blackrock5.94M0.01%-136.52K
Federated hermes1.94M0.18%-132.30K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp227.13K0.01%227.13K$9.09M
Brandywine global investment management74.11K0.02%74.11K$2.96M
Aurora investment counsel54.47K1.28%54.47K$2.18M
Arkadios wealth advisors25.75K0.07%25.75K$1.03M
Alphacentric advisors25.00K0.74%25.00K$1.00M

Sold Out

HolderChange
Financial gravity asset management-1.00
Nelson, van denburg & campbell wealth management group-7.00
Financial synergies wealth advisors-15.00
First horizon advisors-36.00
Private wealth management group-40.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242802.94%35,359,6972.73%721.47%140-93-4.12%
Jun 30, 2024268-1.83%34,405,3022.58%711.47%1382.99%96-1.03%
Mar 31, 2024273-2.85%33,540,0170.70%691.46%134-8.84%976.59%
Dec 31, 20232819.34%33,305,4864.00%691.60%14714.84%91-1.09%
Sep 30, 20232573.21%32,023,9141.99%651.56%128-0.78%922.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.42M5.00%2.38K
Federated Hermes Kaufmann Small Cap A1.31M2.68%-
Federated Hermes Kaufmann Small Cap Grow1.31M2.68%-
FullerThaler Behavioral Small-Cap Equity1.20M2.45%-
FullerThaler Behavioral Sm-Cp Eq R61.20M2.45%-
Vanguard Total Stock Mkt Idx Inv1.14M2.35%-8.53K
Neuberger Berman Genesis Inv1.07M2.18%-5.33K
iShares Russell 2000 ETF988.77K2.04%-2.23K
TD U.S. Capital Reinvestment I736.00K1.50%-34.00K
Federated Hermes Kaufmann Growth615.00K1.26%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 12, 2024Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$310.98K
Dec 13, 2024Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$361.84K
Dec 09, 2024PRINS RICHARD K-Sell$437.70K
Nov 12, 2024Zhou Rong SENIOR EVP, PRODUCTION CENTERSell$336.93K
Nov 12, 2024PRINS RICHARD K-Sell$243.99K

Insider Transactions Trends


DateBuySell
2024 Q4-5
2024 Q3-5
2024 Q2-6
2024 Q1-25
2023 Q4-12

AMPH Ownership FAQ


Who Owns Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals shareholders are primarily institutional investors at 72.73%, followed by 22.41% insiders and 4.86% retail investors. The average institutional ownership in Amphastar Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which Amphastar Pharmaceuticals exceeds.

Who owns the most shares of Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals’s largest shareholders are Blackrock (5.94M shares, 12.33%), Vanguard group (2.67M shares, 5.54%), and Federated hermes (1.94M shares, 4.03%). Together, they hold 21.90% of Amphastar Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amphastar Pharmaceuticals?

Yes, BlackRock owns 12.33% of Amphastar Pharmaceuticals, totaling 5.94M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 237.7M$. In the last quarter, BlackRock decreased its holdings by -137K shares, a -2.25% change.

Who is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Boone capital management is Amphastar Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.17% of its assets in 495.09K Amphastar Pharmaceuticals shares, valued at 19.8M$.

Who is the top mutual fund holder of Amphastar Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amphastar Pharmaceuticals shares, with 5.00% of its total shares outstanding invested in 2.42M Amphastar Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools